⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyrrolidine SCHEMBL1010986 | 0.79 | ALDH1A1 (0.36) | — | |
| SCHEMBL692716 | 0.75 | — | — | |
| SCHEMBL44759 | 0.75 | — | — | |
| SCHEMBL27588236 | 0.74 | — | — | |
| SCHEMBL25169780 | 0.72 | — | — | |
| SCHEMBL20915652 | 0.72 | — | — | |
| SCHEMBL836624 | 0.72 | — | — | |
| SCHEMBL25227005 | 0.72 | — | — | |
| SCHEMBL25241362 | 0.72 | — | — | |
| SCHEMBL3750293 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12570668-B2 | Single molecule compounds providing multi-target inhibition of BTK and other proteins and methods of use thereof | SIGNALRX PHARMACEUTICALS, INC. (US) | 2026-03-10 | — | — | US | claimed |
| US-20250093362-A1 | HIGH-THROUGHPUT ENGINEERING OF MOLECULAR GLUES | FRONTIER MEDICINES CORPORATION | 2025-03-20 | — | — | US | claimed |
| US-20240002343-A1 | COMPOUNDS HAVING INHIBITORY EFFECT ON MITOCHONDRIAL HYPERFISSION | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2024-01-04 | — | — | US | claimed |
| EP-4252843-A1 | COMPOUND HAVING INHIBITORY ACTION AGAINST EXCESSIVE MITOCHONDRIAL DIVISIONS | Kyushu University, National University Corporation (JP) | 2023-10-04 | — | — | EP | claimed |
| US-20230220313-A1 | COMPOSITION AND METHOD FOR INACTIVATING A VIRUS | RNASSIST LTD. (GB) | 2023-07-13 | — | — | US | claimed |
| EP-4133062-A1 | COMPOSITION AND METHOD FOR INACTIVATING A VIRUS | Rnassist Limited (GB) | 2023-02-15 | — | — | EP | claimed |
| WO-2023015237-A1 | HIGH-THROUGHPUT ENGINEERING OF MOLECULAR GLUES | FRONTIER MEDICINES CORPORATION (US) | 2023-02-09 | — | — | WO | claimed |
| WO-2022114187-A1 | COMPOUND HAVING INHIBITORY ACTION AGAINST EXCESSIVE MITOCHONDRIAL DIVISIONS | 国立大学法人九州大学 | 2022-06-02 | — | — | WO | claimed |
| US-20260125421-A1 | ANTIVIRAL COMPOUNDS | HOFFMANN-LA ROCHE INC. (US) | 2026-05-07 | — | — | US | disclosed |
| US-12570668-B2 | Single molecule compounds providing multi-target inhibition of BTK and other proteins and methods of use thereof | SIGNALRX PHARMACEUTICALS, INC. (US) | 2026-03-10 | — | — | US | disclosed |
| WO-2025262036-A1 | METHOD OF MANUFACTURING A PHARMACEUTICAL COMPOSITION | RNASSIST LTD (GB) | 2025-12-26 | — | — | WO | disclosed |
| EP-4532503-A1 | HALOINDOLE MACROCYCLIC COMPOUNDS FOR THE TREATMENT OF CANCER | F. Hoffmann-La Roche AG (CH) | 2025-04-09 | — | — | EP | disclosed |
| US-20250093362-A1 | HIGH-THROUGHPUT ENGINEERING OF MOLECULAR GLUES | FRONTIER MEDICINES CORPORATION | 2025-03-20 | — | — | US | disclosed |
| EP-4392424-A1 | MACROCYCLIC COMPOUNDS FOR THE TREATMENT OF CANCER | F. Hoffmann-La Roche AG (CH) | 2024-07-03 | — | — | EP | disclosed |
| US-4670593-A | Haloacetamidines and the herbicidal use thereof | STAUFFER CHEMICAL CO. (US) | 1987-06-02 | — | — | US | disclosed |
| US-4562009-A | Halonitriles, their preparation and use to make halopyridines | THE DOW CHEMICAL COMPANY (US) | 1985-12-31 | — | — | US | disclosed |
| EP-0143465-A2 | Novel halonitriles and their preparation | THE DOW CHEMICAL COMPANY (US) | 1985-06-05 | — | — | EP | disclosed |
| US-4361557-A | 1-Aryl-2-acylamido-3-fluoro-1-propanol acylates, methods for their use as anti-bacterial agents and compositions useful therefor | SCHERING CORPORATION (US) | 1982-11-30 | — | — | US | disclosed |
| US-4311857-A | 1-Aryl-2-acylamido-3-fluoro-1-propanol acylates, methods for their manufacture and intermediates useful therein, methods for their use as antibacterial agents and compositions useful therefor | SCHERING CORPORATION (US) | 1982-01-19 | — | — | US | disclosed |
| US-4235892-A | AROMATIC ANTIBIOTICS | Schering Corporation, Patent Dept. (US) | 1980-11-25 | — | — | US | disclosed |